Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Pfizer Inc
Femme et Homme Max 99 ans
Pfizer Inc.235 East 42nd Street, New York, NY 10017
MAJ Il y a 4 ans
A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGING STUDY EVALUATING THE EFFICACY AND SAFETY OF TANEZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH INTERSTITIAL CYSTITIS/ PAINFUL BLADDER SYNDROME (IC/PBS)
To characterize the dose response for tanezumab when administered by SC injection at an 8-weekly interval (2 injections) for moderate to severe chronic pain associated with (IC/PBS). To evaluate the...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Inc
MAJ Il y a 4 ans
AXITINIB (AG-013736) AS SECOND LINE THERAPY FOR METASTATIC RENAL CELL CANCER: AXIS TRIAL AXITINIB (AG 013736) COME TRATTAMENTO DI SECONDA LINEA PER L'ADENOCARCINOMA RENALE METASTATICO (AXIS)
Compare the Progression-Free Survival (PFS) of patients with mRCC receiving AG-013736 (axitinib) vs sorafenib following failure of one prior systemic first-line regimen containing one or more of the...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Inc., 235 East 42nd Street, New York, NY 110017
MAJ Il y a 4 ans
PHASE 1 SAFETY AND TOLERABILITY STUDY OF FIGITUMUMAB COMBINED WITH PEGVISOMANT IN PATIENTS WITH ADVANCED SOLID TUMORS
To evaluate the safety and tolerability of figitumumab plus pegvisomant in patients with advanced solid tumors.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Inc.235 East 42nd Street, New York, NY 10017
MAJ Il y a 4 ans
PILOT STUDY OF NOVEL COMBINATION OF MARAVIROC +ATAZANAVIR/RITONAVIR VS ATAZANAVIR/RITONAVIR +EMTRICITABINE/TENOFOVIR FOR THE TREATMENT OF TREATMENT NAÏVE HIV-INFECTED PATIENTS WITH R5 HIV-1
To examine if the combination of maraviroc (SelzentryTM, Celsentri®) and atazanavir/ritonavir is effective for the treatment of treatment-naïve HIV-1 infected subjects as measured by the percentage of...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Inc.235 East 42nd Street, New York, NY 10017
MAJ Il y a 4 ans
Study to test whether PF-06480605 is safe and improves symptoms in patients with ulcerative colitis
- To evaluate the safety and tolerability of PF-06480605 in subjects with moderate to severe UC. - To evaluate the efficacy of PF-06480605 in induction of endoscopic improvement (as assessed by Mayo ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Inc.235 East 42nd Street, New York, NY 10017
MAJ Il y a 4 ans
Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®
To assess the impact of prophylactic paracetamol or ibuprofen administration on the immunogenicity of 13vPnC as measured by serotype-specific IgG geometric mean concentrations (GMCs) after completio...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer B.V. (The Netherlands) (Pfizer Inc, New York, USA)
MAJ Il y a 4 ans
A study on the tissue responsiveness to short term exogenous growth hormone in children with idiopathic short stature in relation to their response to long-term treatment
Not provided at time of registration
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Inc
MAJ Il y a 4 ans
A 12-WEEK PROOF OF CONCEPT STUDY FOR PF-04991532 IN T2DM SUBJECTS
To evaluate the dose response of PF 04991532 administered once daily over 12 weeks on HbA1c in adults with T2DM on stable doses of metformin.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Inc.235 East 42nd Street, New York, NY 10017
MAJ Il y a 4 ans
A Phase I/II Study of Sunitinib in Young Patients with Advanced Gastrointestinal Stromal Tumor
To characterize the plasma PK profile of sunitinib and its active metabolite SU012662 in children and young adults with advanced GIST.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Inc.235 East 42nd Street, New York, NY 10017
MAJ Il y a 4 ans
A clinical trial to determine if the investigational MnB vaccine works the same every time a batch (or lot) of the vaccine is made
Co-Primary To demonstrate that the immune response induced by 3 lots of rLP2086 vaccine are equivalent as measured by serum bactericidal assay using human complement (hSBA) performed with MnB strai...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Précédent
8
9
10
11
12
13
14
15
16
17
Suivant